Abraham Ceesay, Director: Pacira BioSciences PCRX Planned sale · Filed 06/12

Trade details

Type: Planned sale notice
Stock: Pacira BioSciences PCRX
Person: Abraham CeesayDirector
Planned sale date: 26/06/12
Filed: 26/06/12

$210.4K to be sold

Pacira BioSciences trades, last 26 weeks

What else happened in Pacira BioSciences around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Abraham Ceesay's recent trades

Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$76.2K
1,952 sh
$76.2K
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$8,570
215 sh
$8,570
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$1,765
43 sh
$1,765
Filed 09/24
Traded 09/23
Abraham CeesayCEO
Planned sale10b5-1 planRapport Therapeutics
Planned sale10b5-1 plan
Rapport Therapeutics
RAPP
$4M
99,480 sh
$4M
Filed 06/29
Traded 06/29
Abraham CeesayCEO
Sell10b5-1 planRapport Therapeutics
Sell10b5-1 plan
Rapport Therapeutics
RAPP
$103.2K
3,552 sh
$103.2K
Filed 02/19
Traded 02/18